Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent Advances in Cell Sheet Engineering: From Fabrication to Clinical Translation. | Bioengineering (Basel) | 2023 | 36829705 | PubTator, text mining | PubMed |
| Mitochondrial DNA variants in a cohort from Argentina with suspected Leber's hereditary optic neuropathy (LHON). | PLoS One | 2023 | 36827238 | PubTator, text mining | PubMed |
| Progressive external ophthalmoplegia. | Handb Clin Neurol | 2023 | 36813323 | PubTator, text mining | PubMed |
| Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome - A literature review. | An Bras Dermatol | 2023 | 36803558 | PubTator, text mining | PubMed |
| Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. | J Natl Med Assoc | 2023 | 36801148 | PubTator, text mining | PubMed |
| Integrated Analysis of Transcriptome Changes in Osteoarthritis: Gene Expression, Pathways and Alternative Splicing. | Cartilage | 2023 | 36799242 | PubTator, text mining | PubMed |
| Survival improvement for patients with metastatic colorectal cancer over twenty years. | NPJ Precis Oncol | 2023 | 36781990 | PubTator, text mining | PubMed |
| Clinical and biochemical footprints of inherited metabolic disorders. XI. Gastrointestinal symptoms. | Mol Genet Metab | 2023 | 36774919 | PubTator, text mining | PubMed |
| Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase. | J Biol Chem | 2023 | 36773803 | PubTator, text mining | PubMed |
| The Efficacy of Using Patient-Derived Organoids to Predict Treatment Response in Colorectal Cancer. | Cancers (Basel) | 2023 | 36765763 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation. | Immunity | 2023 | 36750099 | PubTator, text mining | PubMed |
| Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis. | Ther Adv Med Oncol | 2023 | 36743525 | PubTator, text mining | PubMed |
| Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform. | Int J Nanomedicine | 2023 | 36742991 | PubTator, text mining | PubMed |
| Platelet-Rich Plasma Treatment for Chronic Respiratory Disease. | Cureus | 2023 | 36741673 | PubTator, text mining | PubMed |
| AZD6738 promotes the tumor suppressive effects of trifluridine in colorectal cancer cells. | Oncol Rep | 2023 | 36734271 | PubTator, text mining | PubMed |
| Non-canonical functions of spliceosome components in cancer progression. | Cell Death Dis | 2023 | 36732501 | PubTator, text mining | PubMed |
| In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer. | Cancer Cell Int | 2023 | 36717845 | PubTator, text mining | PubMed |
| The development of BVDU: An odyssey. | Antivir Chem Chemother | 2023 | 36710501 | PubTator, text mining | PubMed |
| Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. | BMC Cancer | 2023 | 36707808 | PubTator, text mining | PubMed |
| Hypoxia signaling in cancer: Implications for therapeutic interventions. | MedComm (2020) | 2023 | 36703877 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=19